Literature DB >> 28034636

Detection of Fusobacterium nucleatum in two cases of empyema and lung abscess using paromomycin-vancomycin supplemented Brucella HK agar.

Kentaro Nagaoka1, Katsunori Yanagihara2, Yoshitomo Morinaga3, Shigeru Kohno4.   

Abstract

Fusobacterium nucleatum was found in patients with empyema or pulmonary abscess, using paromomycin-vancomycin Brucella HK agar. In vitro examination revealed that growth of the strains differed significantly in different media. Clinicians should be aware that suboptimal F. nucleatum cultivation methods may result in an underestimation of its frequency.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaerobes; Empyema; Fusobacterium nucleatum; Lung abscess

Mesh：

Substances：

Year:  2016        PMID： 28034636     DOI： 10.1016/j.anaerobe.2016.12.011

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  3 in total

1.  Fusobacterium Nucleatum Empyema: An Atypical Presentation.

Authors:  Lucía Barrera-López; Cristina Macía-Rodríguez; Lucía Ferreiro-Fernández; José Antonio Díaz-Peromingo
Journal:  Eur J Case Rep Intern Med       Date:  2020-04-24

2.  Fusobacterium nucleatum Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT/MAPK and NF-κB Signaling Pathways in Human Gingival Fibroblasts.

Authors:  Wenyan Kang; Zhilong Jia; Di Tang; Zhanwei Zhang; Hui Gao; Kunlun He; Qiang Feng
Journal:  Oxid Med Cell Longev       Date:  2019-10-13       Impact factor: 6.543

3.  Oral Pathogen Fusobacterium nucleatum Coaggregates With Pseudomonas aeruginosa to Modulate the Inflammatory Cytotoxicity of Pulmonary Epithelial Cells.

Authors:  Qian Li; Hongyan Wang; Lisi Tan; Shuwei Zhang; Li Lin; Xiaolin Tang; Yaping Pan
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.